Skip Navigation

European Heart Journal 2004 25(7):535-536; doi:10.1016/j.ehj.2004.03.002
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Breithardt, O. A
Right arrow Articles by Sutherland, G. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Breithardt, O. A
Right arrow Articles by Sutherland, G. R
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Do we understand who benefits from resynchronisation therapy?

Ole A Breithardta,*, Piet Clausb and George R Sutherlandb

a Department of Cardiology, University Hospital Aachen, D-52057 Aachen, Germany
b Department of Cardiology, University Hospital Gasthuisberg, Catholic University Leuven, Belgium

* Corresponding author. Tel.: +49-2418089301; fax: +49-2418082414
E-mail address: olebreithardt@gmx.de

The first 10% of the full text of this article appears below.

This editorial refers to "Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration"1 by S. Ghio et al. on page 571

Interest in ventricular dyssynchrony in heart failure patients has been renewed recently by the introduction of cardiac resynchronisation therapy (CRT). CRT is currently accepted as an adjunct to the medical treatment of symptomatic heart failure in patients with severe left ventricular systolic dysfunction and ECG manifestations of ventricular conduction delay.1 It aims to reduce the electrical conduction delay by pre-excitation of late-activated regions with left- or biventricular pacing to restore a more synchronous contraction pattern. Although this strategy has been proven to be effective at group . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration
Stefano Ghio, Cristina Constantin, Catherine Klersy, Alessandra Serio, Alessandra Fontana, Carlo Campana, and Luigi Tavazzi
EHJ 2004 25: 571-578. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 EuropaceHome page
E. Donal, N. Vignat, C. De Place, E. Leray, C. Crocq, P. Mabo, J.-C. Daubert, and C. Leclercq
Acute effects of biventricular pacing on right ventricular function assessed by tissue Doppler imaging
Europace, February 1, 2007; 9(2): 108 - 112.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M Galderisi and S Mondillo
Tissue Doppler and cardiac resynchronisation therapy: a new challenge for the optimal choice of candidates
Eur. Heart J., August 1, 2004; 25(15): 1363 - 1363.
[Full Text] [PDF]